Vanguard Personalized Indexing Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Buy |
+15,329
| New | +$214K | ﹤0.01% | 1595 |
|
|
2025
Q1 | – | Sell |
-11,377
| Closed | -$232K | – | 1863 |
|
|
2024
Q4 | $232K | Sell |
11,377
-1,513
| -12% | -$30.8K | ﹤0.01% | 1458 |
|
|
2024
Q3 | $375K | Buy |
12,890
+2,100
| +19% | +$61.2K | 0.01% | 1242 |
|
|
2024
Q2 | $249K | Buy |
+10,790
| New | +$249K | ﹤0.01% | 1355 |
|
|
2021
Q3 | – | Sell |
-6,012
| Closed | -$472K | – | 1001 |
|
|
2021
Q2 | $472K | Buy |
+6,012
| New | +$472K | 0.05% | 505 |
|